Researchers track 300 liver cancer patients to find best treatment sequence
NCT ID NCT06117891
Summary
This study aims to understand which treatments work best for advanced liver cancer after patients have received initial immunotherapy combinations. Researchers will collect data from 300 adults who have already started their next treatment as part of their regular care. The study will track how long patients live and how their cancer responds to different treatment sequences, without providing any new treatments or requiring extra visits.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UNRESECTABLE HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Corporal Michael J Crescenz Department Of Veterans Affairs Medical Center
NOT_YET_RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
-
Einstein Medical Center
NOT_YET_RECRUITINGPhiladelphia, Pennsylvania, 19141, United States
-
Many Locations
RECRUITINGMultiple Locations, Argentina
-
Many Locations
ACTIVE_NOT_RECRUITINGMultiple Locations, Brazil
-
Many Locations
RECRUITINGMultiple Locations, China
-
Many Locations
RECRUITINGMultiple Locations, Colombia
-
Many Locations
ACTIVE_NOT_RECRUITINGMultiple Locations, France
-
Many Locations
ACTIVE_NOT_RECRUITINGMultiple Locations, Greece
-
Many Locations
ACTIVE_NOT_RECRUITINGMultiple Locations, Italy
-
Many Locations
WITHDRAWNMultiple Locations, Mexico
-
Many Locations
NOT_YET_RECRUITINGMultiple Locations, Saudi Arabia
-
Many Locations
ACTIVE_NOT_RECRUITINGMultiple Locations, South Korea
-
Many Locations
ACTIVE_NOT_RECRUITINGMultiple Locations, Spain
-
Many Locations
RECRUITINGMultiple Locations, Taiwan
-
Many Locations
ACTIVE_NOT_RECRUITINGMultiple Locations, Thailand
-
Many Locations
WITHDRAWNMultiple Locations, Turkey (Türkiye)
-
Mercy Medical Center - Medline Healthcare Services LLC
NOT_YET_RECRUITINGBaltimore, Maryland, 21202, United States
-
Roswell Park Comprehensive Cancer Center
NOT_YET_RECRUITINGBuffalo, New York, 14203, United States
-
University Of Cincinnati Division Of Hematology Oncology - UC Health System
NOT_YET_RECRUITINGCincinnati, Ohio, 45219, United States
-
University of Michigan Health System
NOT_YET_RECRUITINGAnn Arbor, Michigan, 48109, United States
Conditions
Explore the condition pages connected to this study.